|
- 2018
网织血小板与早发冠心病PCI术后远期预后的相关性
|
Abstract:
摘要:目的 探讨网织血小板(reticulated platelets, RPs)与早发冠状动脉疾病(premature coronary artery disease, PCAD)经皮冠状动脉介入术(percutaneous coronary intervention, PCI)后远期预后的相关性。方法 共纳入300例PCAD患者(冠心病发病年龄男性<45岁,女性<55岁)及冠脉造影正常者250例为对照组。用双标记流式细胞仪对全血进行检测获得RPs百分比(RPs%)。随访24月时,评估RPs与远期主要不良心脏血管事件(major adverse cardiac event, MACE)及冠脉支架内再狭窄(in-stent restenosis, ISR)的相关性。结果 随访24月共发生MACE 20例(占6.7%)。PCAD组与对照组的吸烟、糖尿病、家族史、心力衰竭史差异均有统计学意义;PCAD组RPs显著高于对照组,差异有统计学意义(P<0.05)。RPs>10%组ISR的发生率与RPs 6%~8%组的差异有统计学意义(P<0.05)。Cox比例风险回归分析RPs>10%是预测心脏不良事件的一个独立变量(HR=2.58,95%可信区间:1.12~5.35,P<0.01)。Kaplan-Meier事件生存率曲线显示,RPs>10%组的心血管事件发生率高于RPs<10%组。 结论 RPs是预测PCAD行PCI术后远期预后的独立分子标志物。RPs>10%与PCAD患者PCI术后ISR相关,且MACE发生率高。
ABSTRACT: Objective?? To investigate the assocaition between reticulated platelets (RPs) and long-term outcomes of premature coronary artery disease (PCAD) patients after percutaneous coronary intervention (PCI). Methods? ?We recruited 300 PCAD patients (males aged <45 years and females aged <55 years at the onset of coronary artery disease) and 250 controls with normal coronary angiographic results. RPs percentage was assessed using a direct, whole blood, dual-labeling flow cytometric method. We evaluated the association of RPs with long-term major adverse cardiac events (MACE) after 24-month follow-up and coronary in-stent restenosis (ISR). Results?? There were 20 cardiac events (6.7%) during the 24-month follow-up. PCAD and control groups differed significantly in smoking, diabetes, family history, and history of heart failure. RPs were significantly higher in PCAD group than in control group (P<0.05). The incidence of ISR in RPs>10% group was significantly different from that in RPs 6%-8% group (P<0.05). Cox proportional hazard regression analysis of RPs>10% was an independent variable in predicting MACE (HR=2.58, 95% CI: 1.12-5.35, P<0.01). Kaplan-Meier event survival curve showed that the incidence of cardiovascular events in RPs>10% group was higher than that in RPs <10% group. Conclusion? ?RPs are an independent molecular marker for predicting the long-term outcomes in PCAD after PCI. RPs>10% are associated with ISR in patients with PCAD after PCI, and the incidence of MACE is increased
[1] | FUCHS S, KORNOWSKI R, MEHRAN R, et al. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions[J]. Am J Cardiol, 2009, 85(8):1077-1082. |
[2] | OMER W, NAVEED AK, KHAN OJ, et al. Role of cytokine gene score in risk prediction of premature coronary artery disease[J]. Genet Test Mol Biomarkers, 2016, 20(11):685-691. |
[3] | NAGEH T, SHERWOOD RA, HARRIS BM, et al. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention[J]. Int J Cardiol, 2013, 92(9):285-293. |
[4] | MACCHI I, CHAMLIAN V, SADOUN A, et al. Comparison of reticulated platelet count and mean platelet volume determination in the evaluation of bone marrow recovery after aplastic chemotherapy[J]. Eur J Haematol Sep, 2012, 69(3):152-157. |
[5] | IBRAHIM H, NADIPALLI S, USMANI S, et al. Detection and quantification of circulating immature platelets: Agreement between flow cytometric and automated detection[J]. J Thromb Thrombolysis, 2016, 42(1):77-83. |
[6] | TAFUR AJ, MCBANE RD, AMMASH N, et al. Impact of atrial fibrillation and sinus rhythm restoration on reticulated platelets[J]. Mayo Clin Proc, 2015, 90(12):1650-1658. |
[7] | LAKKIS N, DOKAINISH H, ABUZAHRA M, et al. Reticulated platelets in acute coronary syndrome: A marker of platelet activity[J]. J Am Coll Cardiol, 2014, 44(6):2091-2093. |
[8] | MATIC GB, CHAPMAN ES, ZAISS M, et al. Whole blood analysis of reticulated platelets: Improvements of detection and assay stability[J]. Cytometry, 2008, 34(8):229-234. |
[9] | MCCABE DJ, HARRISON P, SIDHU PS, et al. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack[J]. Br J Haematol, 2014, 126(11):861-869. |
[10] | HEDLEY BD, LLEWELLYN-SMITH N, LANG S, et al. Combined accurate platelet enumeration and reticulated platelet determination by flow cytometry[J]. Cytometry B Clin Cytom, 2015, 88(5):330-337. |
[11] | SANDRO CG, MARINO L, MICHEL LM. Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention[J]. Am J Cardiology, 2011, 35(5):204-209. |